share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股SEC公告 ·  05/16 23:56

牛牛AI助理已提取核心訊息

Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 15, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The action reflects a change in Bourla's holdings in the company, but the specific nature and impact on his total share ownership remain unspecified. Investors are advised to monitor official filings for complete transaction details.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 15, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The action reflects a change in Bourla's holdings in the company, but the specific nature and impact on his total share ownership remain unspecified. Investors are advised to monitor official filings for complete transaction details.
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布爾拉於2024年5月15日執行了一筆非衍生證券交易。該交易的細節,包括所涉及的股票數量和交易價格,尚未披露。該行動反映了Bourla持有的公司股權的變化,但其具體性質及其對總股權的影響仍未具體說明。建議投資者監督官方申報的完整交易細節。
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布爾拉於2024年5月15日執行了一筆非衍生證券交易。該交易的細節,包括所涉及的股票數量和交易價格,尚未披露。該行動反映了Bourla持有的公司股權的變化,但其具體性質及其對總股權的影響仍未具體說明。建議投資者監督官方申報的完整交易細節。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。